Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP2 | P42575 | 2/20 | 0.39 |
| ▸ | CA12 | O43570 | 2/20 | 0.39 |
| ▸ | F13A1 | P00488 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.39 |
| ▸ | CA4 | P22748 | 2/20 | 0.39 |
| ▸ | CA6 | P23280 | 2/20 | 0.39 |
| ▸ | CA5A | P35218 | 2/20 | 0.39 |
| ▸ | THPO | P40225 | 2/20 | 0.39 |
| ▸ | CA7 | P43166 | 2/20 | 0.39 |
| ▸ | CA9 | Q16790 | 2/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.39 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 4/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29314419 | 0.84 | CA12 (0.36) | CA12CA2ALOX15CA4CA6 | |
| SCHEMBL2428717 | 0.83 | CA12 (0.43) | CASP2CA12F13A1CA2CYP1A2 | |
| SCHEMBL29314423 | 0.81 | CA12 (0.42) | CASP2CA12F13A1CA2CYP1A2 | |
| SCHEMBL29314583 | 0.79 | CA12 (0.50) | CASP2CA12F13A1CA2CYP1A2 | |
| SCHEMBL197913 | 0.76 | — | — | |
| SCHEMBL21496029 | 0.75 | TSHR (0.44) | CA12CA2ALOX15CA7CA14 | |
| SCHEMBL15170563 | 0.74 | CA12 (0.39) | CASP2CA12CA2ALOX15CA4 | |
| SCHEMBL17931060 | 0.74 | CASP2 (0.72) | CASP2CA12F13A1CA2CYP1A2 | |
| Hydrochloric Acid SCHEMBL9343695 | 0.74 | UBE2N (0.68) | CASP2CA12F13A1CA2CYP1A2 | |
| SCHEMBL8190944 | 0.74 | CA12 (0.63) | CASP2CA12F13A1CA2CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240239819-A1 | SYNTHESIS OF AMINOALKYL-SUBSTITUTED DISILOXANES | GE INFRASTRUCTURE TECHNOLOGY LLC | 2024-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240239819-A1 | SYNTHESIS OF AMINOALKYL-SUBSTITUTED DISILOXANES | SRM, DAO, SMOX | CASP2 1615/4885CA12 4214/4885F13A1 1842/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.